publicly traded companies glp-1 receptor agonist manufacturers Market Size, Trends and Share Report 2026 GLP-1 Receptor Agonist Market Size
Description
This outcome included the effect of weight loss medication use, reaching clinically significant weight loss thresholds defined as loss of 5%, 10%, and 15% of baseline weight
It fundamentally changes what this class of drugs can achieve
For most users, gastrointestinal side effects are most pronounced during the first few weeks and tend to improve as the body adjusts
GLP-1s are primarily indicated for obesity and diabetes, two major global health challenges that continue to grow at alarming rates
Journal of American Heart Association , 10
